126 related articles for article (PubMed ID: 32173487)
1. Upregulation of enzymatic antioxidants in CD4
Nadeem A; Ahmad SF; Al-Harbi NO; Alasmari AF; Al-Ayadhi LY; Alasmari F; Ibrahim KE; Attia SM; Bakheet SA
Biochimie; 2020; 171-172():205-212. PubMed ID: 32173487
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation in IL-6 receptors is associated with upregulated IL-17A related signaling in CD4+ T cells of children with autism.
Nadeem A; Ahmad SF; Attia SM; Al-Ayadhi LY; Al-Harbi NO; Bakheet SA
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109783. PubMed ID: 31655158
[TBL] [Abstract][Full Text] [Related]
3. Oxidative and inflammatory mediators are upregulated in neutrophils of autistic children: Role of IL-17A receptor signaling.
Nadeem A; Ahmad SF; Attia SM; Al-Ayadhi LY; Bakheet SA; Al-Harbi NO
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():204-211. PubMed ID: 30529000
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated enzymatic antioxidant network in peripheral neutrophils and monocytes in children with autism.
Nadeem A; Ahmad SF; Attia SM; Al-Ayadhi LY; Al-Harbi NO; Bakheet SA
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():352-359. PubMed ID: 30145184
[TBL] [Abstract][Full Text] [Related]
5. Activation of IL-17 receptor leads to increased oxidative inflammation in peripheral monocytes of autistic children.
Nadeem A; Ahmad SF; Attia SM; Bakheet SA; Al-Harbi NO; Al-Ayadhi LY
Brain Behav Immun; 2018 Jan; 67():335-344. PubMed ID: 28935156
[TBL] [Abstract][Full Text] [Related]
6. Immune aberrations in children with Autism Spectrum Disorder: a case-control study from a tertiary care neuropsychiatric hospital in India.
Basheer S; Venkataswamy MM; Christopher R; Van Amelsvoort T; Srinath S; Girimaji SC; Ravi V
Psychoneuroendocrinology; 2018 Aug; 94():162-167. PubMed ID: 29804052
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Inflammatory Mediators in Peripheral Blood CD40
Aldossari AA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Ayadhi LY; Alanazi MM; Shahid M; Alwetaid MY; Hussein MH; Ahmad SF
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108638
[TBL] [Abstract][Full Text] [Related]
8. Imbalance in pro-inflammatory and anti-inflammatory cytokines milieu in B cells of children with autism.
Nadeem A; Ahmad SF; Al-Harbi NO; Al-Ayadhi LY; Sarawi W; Attia SM; Bakheet SA; Alqarni SA; Ali N; AsSobeai HM
Mol Immunol; 2022 Jan; 141():297-304. PubMed ID: 34915269
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of toll-like receptor 4 is associated with NADPH oxidase-induced oxidative stress in B cells of children with autism.
Al-Harbi NO; Nadeem A; Ahmad SF; Al-Ayadhi LY; Al-Harbi MM; As Sobeai HM; Ibrahim KE; Bakheet SA
Int Immunopharmacol; 2020 Jul; 84():106555. PubMed ID: 32388012
[TBL] [Abstract][Full Text] [Related]
10. Oxidative Stress in Autism Spectrum Disorder.
Bjørklund G; Meguid NA; El-Bana MA; Tinkov AA; Saad K; Dadar M; Hemimi M; Skalny AV; Hosnedlová B; Kizek R; Osredkar J; Urbina MA; Fabjan T; El-Houfey AA; Kałużna-Czaplińska J; Gątarek P; Chirumbolo S
Mol Neurobiol; 2020 May; 57(5):2314-2332. PubMed ID: 32026227
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of IL-9 and JAK-STAT signaling pathway in children with autism.
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):472-480. PubMed ID: 28802860
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of peripheral CXC and CC chemokine receptor expression on CD4
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():211-220. PubMed ID: 28986277
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of interleukin (IL)-31, a cytokine producing CXCR1 peripheral immune cells, contributes to the immune abnormalities of autism spectrum disorder.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Alsaad AMS; Assiri MA; Al-Mazroua HA; Attia SM
J Neuroimmunol; 2020 Dec; 349():577430. PubMed ID: 33130460
[TBL] [Abstract][Full Text] [Related]
14. Increased oxidative stress in the cerebellum and peripheral immune cells leads to exaggerated autism-like repetitive behavior due to deficiency of antioxidant response in BTBR T + tf/J mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Attia SM; Alshammari MA; Alzahrani KS; Bakheet SA
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():245-253. PubMed ID: 30261217
[TBL] [Abstract][Full Text] [Related]
15. IL-17A-induced neutrophilic airway inflammation is mediated by oxidant-antioxidant imbalance and inflammatory cytokines in mice.
Nadeem A; Al-Harbi NO; Alfardan AS; Ahmad SF; AlAsmari AF; Al-Harbi MM
Biomed Pharmacother; 2018 Nov; 107():1196-1204. PubMed ID: 30257333
[TBL] [Abstract][Full Text] [Related]
16. A certain role of SOD/CAT imbalance in pathogenesis of autism spectrum disorders.
Yenkoyan K; Harutyunyan H; Harutyunyan A
Free Radic Biol Med; 2018 Aug; 123():85-95. PubMed ID: 29782990
[TBL] [Abstract][Full Text] [Related]
17. Decreased total antioxidant capacity has a larger effect size than increased oxidant levels in urine in individuals with autism spectrum disorder.
Yui K; Tanuma N; Yamada H; Kawasaki Y
Environ Sci Pollut Res Int; 2017 Apr; 24(10):9635-9644. PubMed ID: 28247276
[TBL] [Abstract][Full Text] [Related]
18. Elevated IL-16 expression is associated with development of immune dysfunction in children with autism.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
Psychopharmacology (Berl); 2019 Feb; 236(2):831-838. PubMed ID: 30456538
[TBL] [Abstract][Full Text] [Related]
19. S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Khan MR; Alsaad AMS; Attia SM
Cell Signal; 2018 Dec; 52():127-136. PubMed ID: 30213685
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of the expression of HLA-DR, costimulatory molecule, and chemokine receptors on immune cells in children with autism.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Alotaibi MR; Alhoshani AR; Al-Hosaini KA; Attia SM
Int Immunopharmacol; 2018 Dec; 65():360-365. PubMed ID: 30380510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
